Agnieszka Czechowicz, M.D., Ph.D. is a physician-scientist and Assistant Professor of Pediatrics at Stanford University School of Medicine, specializing in hematopoietic stem cell biology, transplantation, gene therapy, and regenerative medicine.

Agnieszka has over 20 years of experience in stem cell biology and translational research, with a particular focus on developing safer and more effective approaches to hematopoietic stem cell transplantation. Her pioneering research in antibody-based conditioning and targeted stem cell depletion has contributed to the development of novel therapies designed to improve transplantation outcomes and reduce the toxicity associated with conventional conditioning regimens. She has also led clinical trials investigating cell and gene therapies for Fanconi anemia.

Beyond academia, Agnieszka has extensive experience in biotechnology entrepreneurship. She was a scientific co-founder of Magenta Therapeutics and spent nearly a decade consulting with Third Rock Ventures, contributing to the formation and development of companies including Global Blood Therapeutics, bluebird bio, Editas Medicine, and Decibel Therapeutics. Agnieszka earned her M.D. and Ph.D. in Developmental Biology from Stanford University, completed her pediatric residency at Boston Children’s Hospital, and pursued subspecialty training in Pediatric Hematology and Oncology at Dana-Farber Cancer Institute, alongside postdoctoral research at Harvard University.